NSC 663284 – 10 mg

Brand:
Cayman
CAS:
383907-43-5
Storage:
-20
UN-No:
Non-Hazardous - /

Three genes encode dual specificity phosphatases that are Cdc25 homologs. The phosphatases, Cdc25A through C, are proto-oncogenes and are often over-expressed in cancers. NSC 663284 is a potent, cell-permeable, and irreversible inhibitor of all Cdc25 isoforms, with preference for Cdc25A (IC50 = 29, 95, and 89 nM for Cdc25A, Cdc25B2, and Cdc25C, respectively).{17980} NSC 663284 poorly inhibits other phosphatases, including Vaccinia virus VH1-related (IC50 = 4.0 μM), PTP1B (no inhibition), and the mitogen-activated protein kinase phosphatases (MKP) MKP-1 or -3 (no inhibition).{17980,17978} By inhibiting Cdc25 isoforms, NSC 663284 prevents the dephosphorylation and activation of Cdk1 and Cdk2,{17979,17981} arrests cells at both G1 and G2/M phases,{17979} and prevents the proliferation of several human tumor cell lines.{17980,17979,17982}  

 

SKU: - Category:

Description

A potent, cell-permeable, and irreversible inhibitor of all Cdc25 isoforms, with preference for Cdc25A (IC50 = 29, 95, and 89 nM for Cdc25A, Cdc25B2, and Cdc25C, respectively); arrests cells at both G1 and G2/M phases and prevents the proliferation of several human tumor cell lines


Formal name: 6-chloro-7-[[2-(4-morpholinyl)ethyl]amino]-5,8-quinolinedione

Synonyms:  Cdc25 Phosphatase Inhibitor II|DA-3003-1|SPS8I1

Molecular weight: 321.8

CAS: 383907-43-5

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Phosphatases||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Cycle|G2/M